Author

L. Communal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A.-M. Mes-Masson· 2 shared D. Provencher· 2 shared A. Lazaris· 1 shared A. Meunier· 1 shared A. Ng· 1 shared B. Peant· 1 shared D. Juncker· 1 shared F. Rodier· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A.-M. Mes-Masson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gravity-based microfiltration reveals unexpected prevalence of circulating tumor cell clusters in ovarian and colorectal cancer

A. Meunier, J. A. Hernandez-Castro, N. Chahley, L. Communal, S. Kheireddine, N. Koushki, N. Davoudvandi, S. Al Habyan, B. Peant, A. Lazaris, A. Ng, T. Veres, L. McCaffrey, D. Provencher, P. Metrakos, , D. Juncker

This study introduces gravity-based microfiltration to isolate CTC clusters, finding they are prevalent in ovarian and colorectal cancer patients.

bioRxiv · Dec 5, 2023Bioengineering

53BP1 mediates sensitivity to chemotherapy and is associated with poor clinical outcomes in high-grade serous ovarian cancer

M. Skulimowski, J. Bourbonnais, N. Malaquin, H. Fleury, I. Clement, L. Communal, K. Rahimi, D. Provencher, A.-M. Mes-Masson, F. Rodier

This study shows that high 53BP1 levels in ovarian cancer are linked to poor survival and chemotherapy resistance, suggesting it could be a therapeutic target.

bioRxiv · Sep 30, 2023 · PreprintCancer Biology